期刊： ANTICANCER RESEARCH, 2023; 43 (3)
Background/Aim: In patients with esophageal cancer, muscle loss induced by neoadjuvant therapy before esophagectomy is correlated with poor prognosis.......
期刊： ANTICANCER RESEARCH, 2023; 43 (5)
Background/Aim: Adult T- cell leukemia ( ATL) is a peripheral T-lymphocytic malignancy influenced by human T-cell leukemia virus type 1 (HTLV-1) infec......
期刊： ANTICANCER RESEARCH, 2023; 43 (5)
Background/Aim: Considering the limited data available on immune checkpoint inhibitors and radiation combination therapy in advanced urothelial carcin......
期刊： ANTICANCER RESEARCH, 2023; 43 (5)
Background/Aim: Sarcoma patients' experiences of their health-related quality of life and late effects following particle therapy are sparse. Such kno......
期刊： ANTICANCER RESEARCH, 2023; 43 (8)
Background/Aim: Pseudoaneurysm rupture (PR) after subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) is a potentially fatal complication. Pat......
期刊： ANTICANCER RESEARCH, 2023; 43 (9)
Otorhinolaryngology tradition is that tonsillectomy (TE) is conducted among children and adolescents for obstructive sleep apnea secondary to adenoton......
期刊： ANTICANCER RESEARCH, 2023; 43 (9)
Background/Aim: Distinguishing gastrointestinal involvement in classic follicular lymphoma (CFL) and duodenal-type follicular lymphoma (DFL) is crucia......
期刊： ANTICANCER RESEARCH, 2023; 43 (10)
Background/Aim: In addition to its established role in regulating circadian rhythms and reducing inflammation, melatonin has been demonstrated to poss......
期刊： ANTICANCER RESEARCH, 2023; 43 (10)
Background/Aim: Clinical trials have shown that the efficacy of a reduced dose of cabazitaxel (20 mg/m(2) every 3 weeks) was not inferior to that of t......
期刊： ANTICANCER RESEARCH, 2023; 43 (3)
Background/Aim: Attempts have been made to enhance treatment with vesicular stomatitis virus (VSV) for osteosarcoma. We have previously shown that VSV......
期刊： ANTICANCER RESEARCH, 2023; 43 (3)
Background/Aim: Co-treatment with calcineurin inhibitors, such as tacrolimus and cyclosporin A, can sensitize chemotherapy-resistant cancer cells with......
